US FDA

21 CFR 211.150 - Distribution Procedures

Plain-language explanation, inspection context and common violation patterns.

What it says

Written procedures must be established for drug product distribution, including a system to facilitate stock rotation using the oldest approved stock first, and distribution records adequate to facilitate a recall if necessary, identifying the batch and quantity distributed to each consignee.

Paraphrased for plain-language clarity. Always verify against the current published regulation text.

What it means in practice

What FDA inspectors look for

Most common violation

Distribution records that are complete for direct sale but incomplete or fragmented for distribution through intermediate wholesalers or distributors, creating a genuine gap in recall traceability that is only discovered during a mock recall or, worse, an actual one.

Related regulations

Want a deeper, interactive breakdown?

GMPify's Regulation Explainer tool gives subscribers an AI-powered analysis of any 21 CFR, EU GMP, USP or ICH reference, with live inspection context.

Try the Regulation Explainer →